The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B

MLA

Yi He, et al. “The Efficacy of Pegylated Interferon Alpha-2a and Entecavir in HBeAg-Positive Children and Adolescents with Chronic Hepatitis B.” BMC Pediatrics, vol. 22, no. 1, July 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12887-022-03482-0.

APA

Yi He, Yingzhi Zhou, Huimin Wang, Xiaorong Peng, Yunan Chang, Peng Hu, Hong Ren, & Hongmei Xu. (2022). The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B. BMC Pediatrics, 22(1), 1–11. https://doi.org/10.1186/s12887-022-03482-0

Chicago

Yi He, Yingzhi Zhou, Huimin Wang, Xiaorong Peng, Yunan Chang, Peng Hu, Hong Ren, and Hongmei Xu. 2022. “The Efficacy of Pegylated Interferon Alpha-2a and Entecavir in HBeAg-Positive Children and Adolescents with Chronic Hepatitis B.” BMC Pediatrics 22 (1): 1–11. doi:10.1186/s12887-022-03482-0.